3957 Point Eden Way
Hayward, CA 94545
United States
510 906 4600
https://www.pulsebiosciences.com
Sector(es): Healthcare
Industria: Medical Instruments & Supplies
Empleados a tiempo completo: 61
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Robert W. Duggan | Executive Chairman | N/D | N/D | 1945 |
Mr. Kevin P. Danahy | President & CEO | 393.25k | N/D | 1971 |
Mr. Darrin R. Uecker | CTO & Director | 487.24k | N/D | 1966 |
Mr. Mitchell E. Levinson | Chief Strategy Officer | 361.34k | N/D | 1960 |
Dr. Richard Nuccitelli Ph.D. | Chief Science Officer | N/D | N/D | N/D |
Mr. Kenneth B. Stratton Esq., J.D. | General Counsel & Corporate Secretary | N/D | N/D | 1969 |
Ms. Patty Perla | Vice President of Human Resources | N/D | N/D | N/D |
Mr. David Danitz | Senior Vice President of Engineering | N/D | N/D | N/D |
Dr. Gansevoort Dunnington M.D. | Chief Medical Officer | N/D | N/D | N/D |
Dr. Niv Ad M.D. | Chief Science Officer of Cardiac Surgery | N/D | N/D | N/D |
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. The company was incorporated in 2014 and is headquartered in Hayward, California.
La calificación ISS Governance QuickScore de Pulse Biosciences, Inc. a partir del 1 de marzo de 2024 es 8. Las puntuaciones principales son Auditoría: 3; Junta: 9; Derechos del accionista: 6; Compensación: 9.